Enzo Biochem, Inc. (ENZ)の価格はいくらですか

Enzo Biochem, Inc. (ENZ)の価格は$0.5495です

Enzo Biochem, Inc. (ENZ)の時価総額は何ですか

Enzo Biochem, Inc. (ENZ)の時価総額は$28.14Mです

Enzo Biochem, Inc.（ENZ）発行済株式数

Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.

年	発行済株式数	変化
2026 (TTM)	52.40M	2.95%
2024	50.90M	3.54%
2023	49.16M	1.16%
2022	48.59M	0.84%
2021	48.19M	1.04%
2020	47.70M	0.73%
2019	47.35M	0.93%
2018	46.91M	1.22%
2017	46.35M	0.43%
2016	46.15M	1.76%
2015	45.36M	6.56%
2014	42.56M	7.46%
2013	39.61M	2.09%
2012	38.80M	1.15%
2011	38.36M	0.94%
2010	38.00M	1.31%
2009	37.51M	1.70%
2008	36.88M	5.33%
2007	35.02M	8.70%
2006	32.22M	0.37%
2005	32.10M	1.25%
2004	31.70M	-3.85%
2003	32.97M	5.13%
2002	31.36M	0.34%
2001	31.25M	1.51%
2000	30.79M	0.00%

年

発行済株式数

変化

2026 (TTM)

52.40M

2.95%

2024

50.90M

3.54%

2023

49.16M

1.16%

2022

48.59M

0.84%

2021

48.19M

1.04%

2020

47.70M

0.73%

2019

47.35M

0.93%

2018

46.91M

1.22%

2017

46.35M

0.43%

2016

46.15M

1.76%

2015

45.36M

6.56%

2014

42.56M

7.46%

2013

39.61M

2.09%

2012

38.80M

1.15%

2011

38.36M

0.94%

2010

38.00M

1.31%

2009

37.51M

1.70%

2008

36.88M

5.33%

2007

35.02M

8.70%

2006

32.22M

0.37%

2005

32.10M

1.25%

2004

31.70M

-3.85%

2003

32.97M

5.13%

2002

31.36M

0.34%

2001

31.25M

1.51%

2000

30.79M

0.00%

企業	発行済株式数	差	国
Thermo Fisher Scientific Inc. TMO.US	371.00M	607.97%	US
Danaher Corporation DHR.US	705.30M	1,245.92%	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	143.28M	173.42%	US
IDEXX Laboratories, Inc. IDXX.US	80.10M	52.85%	US

企業

発行済株式数

差

国